S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)

Anixa Biosciences (ANIX) Earnings Date, Estimates & Call Transcripts

$3.42
-0.08 (-2.29%)
(As of 06/9/2023 ET)
Compare
Today's Range
$3.35
$3.51
50-Day Range
$3.06
$5.97
52-Week Range
$2.77
$6.45
Volume
29,834 shs
Average Volume
76,706 shs
Market Capitalization
$105.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.50

Earnings Summary

Upcoming
Earnings Date
Jun. 9Estimated
Actual EPS
(Mar. 16)
-$0.08 Beat By $0.08
Consensus EPS
(Mar. 16)
-$0.16
Last Year's Q1 EPS
(3/11/2022)
-$0.13
Skip Charts & View Estimated and Actual Earnings Data

ANIX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANIX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Anixa Biosciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20231($0.11)($0.11)($0.11)
Q3 20231($0.11)($0.11)($0.11)
Q4 20231($0.11)($0.11)($0.11)
20233($0.33)($0.33)($0.33)
Q1 20241($0.12)($0.12)($0.12)
Q2 20241($0.12)($0.12)($0.12)
Q3 20241($0.11)($0.11)($0.11)
Q4 20241($0.11)($0.11)($0.11)
FY 20244($0.46)($0.46)($0.46)

ANIX Earnings Date and Information

Anixa Biosciences last released its earnings data on March 16th, 2023. The reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.08. Anixa Biosciences has generated ($0.41) earnings per share over the last year (($0.41) diluted earnings per share). Earnings for Anixa Biosciences are expected to grow in the coming year, from ($0.43) to $2.08 per share. Anixa Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 9th, 2023 based off prior year's report dates.

Anixa Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/9/2023
(Estimated)
        
3/16/2023Q1 2023($0.16)($0.08)+$0.08($0.08)
1/4/2023Q4 2022($0.13)($0.12)+$0.01($0.12)
9/9/2022Q3 2022($0.13)($0.09)+$0.04($0.09)
6/10/2022Q2 2022($0.13)($0.12)+$0.01($0.12)
3/11/2022Q1 2022($0.13)($0.13)($0.13)
1/4/2022Q4 2021($0.13)($0.13)($0.13)
8/31/2021Q3($0.08)($0.14)($0.06)($0.14)
6/10/2021Q2 2021($0.08)($0.08)($0.08)
3/11/2021Q1 2021($0.11)($0.09)+$0.02($0.09)$0.51 million
1/7/2021Q4 2020($0.81)($0.81)($0.81)
9/8/2020Q3 2020($0.12)($0.11)+$0.01($0.11)
9/8/2020Q3 2020($0.12)($0.11)+$0.01($0.11)
6/9/2020Q2 2020($0.12)($0.12)($0.12)
6/9/2020Q2 2020($0.12)($0.12)($0.12)
3/9/2020Q1 2020($0.13)($0.13)($0.13)
3/9/2020Q1($0.13)($0.13)($0.13)
1/9/2020Q4 2019($0.10)($0.10)($0.10)
1/9/2020Q4 2019($0.10)($0.10)($0.10)
9/6/2019Q3 2019($0.11)($0.11)($0.11)
9/6/2019Q3 2019($0.11)($0.11)($0.11)
6/11/2019Q2 2019($0.23)($0.13)+$0.10($0.13)$0.25 million
6/11/2019Q2 2019($0.23)($0.13)+$0.10($0.13)$0.25 million
3/13/2019Q1 2019($0.23)($0.23)($0.21)
3/13/2019Q1 2019($0.23)($0.23)($0.21)
9/7/2018Q3 2018($0.30)($0.30)($0.30)$0.36 million
9/7/2018Q3 2018($0.30)($0.30)($0.30)$0.36 million
6/11/2018Q2 2018($0.08)($0.08)($0.08)$0.75 million
6/11/2018Q2 2018($0.08)($0.08)($0.08)$0.75 million
3/9/2018Q1 2018($0.11)($0.11)($0.11)
3/9/2018Q1 2018($0.11)($0.11)($0.11)
9/8/2017Q3 2017($0.12)($0.12)($0.12)$0.36 million
9/8/2017Q3 2017($0.12)($0.12)($0.12)$0.36 million
5/26/2017Q2 2017$0.02+$0.02$0.02
5/26/2017Q2 2017$0.02+$0.02$0.02
3/15/2017Q1 2017($0.41)($0.41)($0.41)
3/15/2017Q1 2017($0.41)($0.41)($0.41)
12/8/2016Q4 2016($0.12)($0.12)($0.12)$0.20 million
12/8/2016Q4 2016($0.12)($0.12)($0.12)$0.20 million
8/19/2016Q3 2016($0.13)($0.13)($0.13)$0.10 million
8/19/2016Q3 2016($0.13)($0.13)($0.13)$0.10 million
5/20/2016Q2 2016($0.15)($0.15)($0.15)
5/20/2016Q2 2016($0.15)($0.15)($0.15)
2/19/2016Q1 2016($0.18)($0.18)($0.18)
2/19/2016Q1 2016($0.18)($0.18)($0.18)
12/22/2015Q4 2015($0.14)($0.14)($0.14)
12/22/2015Q4 2015($0.14)($0.14)($0.14)
8/18/2015Q3 2015($0.18)($0.18)($0.18)$0.10 million
8/18/2015Q3 2015($0.18)($0.18)($0.18)$0.10 million
5/22/2015Q2 2015($0.25)($0.25)($0.25)$0.03 million
5/22/2015Q2 2015($0.25)($0.25)($0.25)$0.03 million
3/9/2015Q1 2015$0.50+$0.50$0.50$9.14 million
3/9/2015Q1 2015$0.50+$0.50$0.50$9.14 million
1/29/2015Q4 2014($0.25)($0.25)($0.25)$1.38 million
1/29/2015Q4 2014($0.25)($0.25)($0.25)$1.38 million
6/16/2014Q2 2014($0.25)($0.25)$1.11 million
6/16/2014Q2 2014($0.25)($0.25)$1.11 million
3/17/2014Q1 2014($0.25)($0.25)
3/17/2014Q1 2014($0.25)($0.25)
1/16/2014Q4 2013($0.25)($0.25)($0.25)$0.39 million
1/16/2014Q4 2013($0.25)($0.25)($0.25)$0.39 million
9/16/2013Q3 2013($0.25)($0.25)($0.25)
9/16/2013Q3 2013($0.25)($0.25)($0.25)
6/14/2013Q2 2013($0.25)($0.25)($0.25)
6/14/2013Q2 2013($0.25)($0.25)($0.25)
3/18/2013Q1 2013($0.25)($0.25)($0.25)
3/18/2013Q1 2013($0.25)($0.25)($0.25)












Anixa Biosciences Earnings - Frequently Asked Questions

When is Anixa Biosciences's earnings date?

Anixa Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 9th, 2023 based off last year's report dates. Learn more on ANIX's earnings history.

Did Anixa Biosciences beat their earnings estimates last quarter?

In the previous quarter, Anixa Biosciences (NASDAQ:ANIX) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.08. Learn more on analysts' earnings estimate vs. ANIX's actual earnings.

How much revenue does Anixa Biosciences generate each year?

Anixa Biosciences (NASDAQ:ANIX) has a recorded annual revenue of $510,000.00.

How much profit does Anixa Biosciences generate each year?

Anixa Biosciences (NASDAQ:ANIX) has a recorded net income of -$13.60 million. ANIX has generated -$0.41 earnings per share over the last four quarters.

What is Anixa Biosciences's EPS forecast for next year?

Anixa Biosciences's earnings are expected to grow from ($0.43) per share to $2.08 per share in the next year.

More Earnings Resources from MarketBeat

This page (NASDAQ:ANIX) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -